MyoGene Bio
Los Angeles
About MyoGene Bio
MyoGene Bio develops therapies for muscle diseases, starting with a gene-editing therapy for Duchenne muscular dystrophy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $900.0K
- Last round: Series Unknown (Nov 2025)
- Website: myogenebio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Genetics, Health Care, Therapeutics, Wellness
Canonical: https://fsome.com/organization/myogene-bio-114274 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.